What is the likely etiology and pathology of a dome‑shaped lesion with a central keratin plug?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Keratoacanthoma

A dome-shaped lesion with a central keratin plug is most likely a keratoacanthoma (KA), a rapidly growing cutaneous neoplasm that arises from the hair follicle infundibulum and presents the critical diagnostic challenge of distinguishing it from squamous cell carcinoma (SCC).

Etiology

The pathogenesis of keratoacanthoma involves multiple contributing factors 1, 2, 3:

  • UV radiation exposure is the primary etiologic factor, with lesions predominantly occurring on sun-exposed skin
  • Trauma may act as a "second insult" following UV damage, triggering koebnerization 4
  • Age-related factors, with mean presentation around 49-57 years old 1, 3
  • Male predominance is consistently observed 1
  • Other risk factors include immunosuppression and, less commonly, HPV infection 4

Pathology

Macroscopic Features

Keratoacanthoma presents as a dome-shaped nodule with a central keratin-filled crater 5, 2, 3. The lesion characteristically grows rapidly over 2-6 weeks, reaching sizes typically under 2 cm 1, 6, 7.

Microscopic Features

The histopathology reveals 5, 2:

  • Crateriform architecture with a central keratin-filled crater
  • Proliferation of enlarged pale pink cells with ground glass-like cytoplasm
  • Absence of significant nuclear atypia (in benign KA)
  • Buttressing of the crater margins
  • Keratin pearls may be present
  • Inflammatory infiltrate in the underlying connective tissue
  • Four recognized stages: early/proliferative, well-developed, regressing, and regressed

Critical Diagnostic Pitfall

The most important clinical consideration is that KA is histologically and clinically indistinguishable from well-differentiated SCC 8, 5, 6, 7. The guidelines explicitly exclude keratoacanthoma from SCC management protocols 8, yet research demonstrates that:

  • KA can undergo malignant transformation within the lesion 5
  • Keratoacanthoma-type crateriform SCC exists as a distinct malignant entity 7
  • Even with complete histologic examination, differentiation can be challenging 5, 6

Management Algorithm

When KA is Clinically Suspected:

  1. Complete excision is mandatory, especially when:

    • Located on sun-exposed areas 5
    • Patient is elderly 5, 3
    • Rapid growth is documented 3, 6, 7
  2. If complete excision is impossible:

    • Perform partial excision with sufficient specimen showing intact architecture 5
    • Implement careful post-biopsy surveillance even if histology confirms KA 5
    • Recognize that conventional SCC may remain in residual tissue 5
  3. Surgical margins:

    • Use 4 mm margins for excision 7
    • Ensure primary closure is feasible
    • Submit entire specimen for histopathologic examination

Post-Treatment Surveillance

  • Monitor for recurrence (reported rate: 6.89%) 1
  • Follow-up at 3 months minimum 7
  • Continued surveillance for new lesions given UV damage field effect

Special Considerations for Skin of Color

Patients with darker skin tones face higher risk of post-operative complications including post-inflammatory hyperpigmentation, hypertrophic scars, and keloids 6. However, the malignant potential of these lesions necessitates complete excision regardless of these risks, as conservative management cannot be justified without definitive histologic diagnosis.

The key principle: treat every dome-shaped lesion with a central keratin plug as potentially malignant until proven otherwise through complete excision and histopathologic examination 5, 6, 7.

Related Questions

What are the likely causes of itchy hypopigmented patches on the arms and legs, and how can they be distinguished and treated?
Can occupational exposure to exhaust, gasoline, mineral oil fumes, solvent vapors, carbon monoxide, petroleum products, and lubricants cause folliculitis, inflammatory pigmentary alteration, or seborrheic keratosis?
In an older patient with a solitary, centrally keratin‑filled crater‑like lesion on the arm, can dermoscopy reliably distinguish keratoacanthoma from squamous cell carcinoma, is it associated with systemic lupus erythematosus or immunodeficiency, does rapid emergence of multiple similar lesions suggest an underlying systemic malignancy, and should the patient be referred promptly because of the risk of bone invasion?
What are the differential diagnoses for painless erythematous papules and plaques with overlying pustules present for three days in a 76-year-old woman?
In a 20‑year‑old with extensive acne, diffuse pustules and nodules on the back, face, and neck, a tender left axillary lymph node, and a history of indoor cat scratches, what are the differential diagnoses and recommended work‑up, and should oral doxycycline be started for 28 days with baseline complete blood count, rapid plasma reagin, and antinuclear antibody screening?
How should I manage a patient with elevated LDL cholesterol on ezetimibe who refuses to take a statin?
What is the appropriate post‑exposure prophylaxis (PEP) regimen for a 27‑year‑old male who may have been exposed to HIV?
What non‑oral medication should be given as first‑line treatment for new‑onset catatonia?
What instructions should be given to patients on how to take doxycycline 100 mg twice daily for rosacea, especially concerning timing with food?
What is the appropriate initiation, titration, and monitoring plan for bupropion maintenance therapy in a 27-year-old woman with mixed anxiety and depressive disorder?
Is it normal to experience lingering anxiety 11 days after discontinuing Latuda (lurasidone)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.